CIBC Bancorp USA »

Cytosorbents shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Cytosorbents (CTSO) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Cytosorbents

Tip: Access up to 7 years of quarterly data

All positions including Cytosorbents held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytosorbents by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2026-03-31 $98k 173k 0.57

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Astrazeneca Ord (AZN)
Eli Lilly & Co. (LLY)
Flutter Entmt SHS (FLUT)
Vanguard Index Fds Mid Cap Etf (VO)
Exxon Mobil Corporation (XOM)

View all positions for CIBC Bancorp USA

Top funds holding Cytosorbents

Avenir Corporation
Vanguard Group
Vanguard Capital Management
Skylands Capital
Neuberger Berman Group
CM Management
BlackRock
Geode Capital Management
Sargent Investment Group
Pathstone Holdings
Vanguard Fiduciary Trust
CIBC Bancorp USA
Atlantic Trust
State Street Corporation
Advisor Group Holdings

View all funds holding Cytosorbents